Skip to main content
SpringerLink
Log in

Overlapping Chronic Pain and Depression: Pathophysiology and Management

  • Chapter
  • First Online:
Understanding Depression

  • 3168 Accesses

Abstract

Depression and chronic pain commonly coexist. Several biological hypotheses regarding pathophysiology of this phenomenon have been proposed. The role of activation of pro-inflammatory cytokines and abnormal glutamatergic neurotransmission has been widely studied in this context. Malfunction of descending 5-HT and nucleus accumbens (NAc) as well as dopaminergic neurons may also explain overlapping pathophysiology for pain and depression. Data from neuroimaging studies showed alterations in regions involved in pain perception and structures considered as a neural basis of depression. These regions include the anterior cingulate cortex (ACC), insular cortex (IC), amygdala, NAc, and prefrontal cortex. Besides their efficiency in depression, antidepressive drugs are also effective in the management of chronic pain . The usefulness of tricyclic antidepressants and serotonin-noradrenaline reuptake inhibitors (SNRIs) in neuropathic pain and functional somatic syndromes (fibromyalgia and irritable bowel syndrome) has been convincingly documented, whereas the superiority of antidepressants from different classes in treatment of painful physical symptoms (PPS) in depression is still a matter of debate.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Amidfar M, Khiabany M, Kohi A, Salardini E, Arbabi M, Roohi Azizi M, Zarrindast MR, Mohammadinejad P, Zeinoddini A, Akhondzadeh S. Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study. J Clin Pharm Ther. 2017;42(1):44–50.

    Article  PubMed  CAS  Google Scholar 

  • Apkarian AV, Sosa Y, Sonty S, Levy RM, Harden RN, Parrish TB, Gitelman DR. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. 2004;24:10410–5.

    Google Scholar 

  • Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain. 2005;9:463–84.

    Google Scholar 

  • Aragona M, Bancheri L, Perinelli D, Tarsitani L, Pizzimenti A, Conte A, Inghilleri M. Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder. Eur J Pain. 2005;9:33–8.

    Article  CAS  PubMed  Google Scholar 

  • Arnold LM, Palmer RH, Ma Y. A 3-year, open-label, flexible-dosing study of milnacipran for the treatment of fibromyalgia. Clin J Pain. 2013;29:1021–8.

    Article  PubMed  Google Scholar 

  • Arnone D, McIntosh AM, Ebmeier KP, MunafĂČ MR, Anderson IM. Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses. Eur Neuropsychopharmacol. 2012;22:116.

    Article  CAS  Google Scholar 

  • Bai YM, Chiou WF, Su TP, Li CT, Chen MH. Pro-inflammatory cytokine associated with somatic and pain symptoms in depression. J Affect Disord. 2014;155:28–34.

    Google Scholar 

  • Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163:2433–45.

    Article  PubMed  Google Scholar 

  • Ball SG, Desaiah D, Spann ME, Zhang Q, Russell JM, Robinson MJ, Demyttenaere K. Efficacy of duloxetine on painful physical symptoms in major depressive disorder for patients with clinically significant painful physical symptoms at baseline: a meta-analysis of 11 double-blind, placebo-controlled clinical trials. Prim Care Companion CNS Disord. 2011;13(6):PCC. 11r01181.

    Google Scholar 

  • BegrĂ© S, Traber M, Gerber M, von KĂ€nel R. Change in pain severity with open label venlafaxine use in patients with a depressive symptomatology: an observational study in primary care. Eur Psychiatry. 2008;23(3):178–86.

    Article  PubMed  Google Scholar 

  • Bittencourt JC, Benoit R, Sawchenko PE. J Chem Neuroanat. 1991;4(1):63–78.

    Article  CAS  PubMed  Google Scholar 

  • Blier P, Gobbi G, Haddjeri N, Santarelli L, Mathew G, Hen R. Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response. J Psychiatry Neurosci. 2004;29(3):208–18.

    PubMed  PubMed Central  Google Scholar 

  • Bondy B, Baghai TC, Minov C, Schule C, Schwarz MJ, Zwanzger P, Rupprecht R, Moller HJ. Substance P serum levels are increased in major depression: preliminary results. Biol Psychiatry. 2003;53(6):538–42.

    Article  CAS  PubMed  Google Scholar 

  • Brannan SK, Mallinckrodt CH, Brown EB, Wohlreich MM, Watkin JG, Schatzberg AF. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. J Psychiatr Res. 2005;39(1):43–53.

    Article  PubMed  Google Scholar 

  • Brennan BP, Fogarty KV, Roberts JL, Reynolds KA, Pope HG Jr, Hudson JI. Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study. Hum Psychopharmacol Clin Exp. 2009;24(5):423–8.

    Article  CAS  Google Scholar 

  • Burgmer M, Gaubitz M, Konrad C, Wrenger M, Hilgart S, Heuft G, Pfleiderer B. Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia. Psychosom Med. 2009;71(5):566–73.

    Article  PubMed  Google Scholar 

  • Busatto GF. Structural and functional neuroimaging studies in major depressive disorder with psychotic features: a critical review. Schizophr Bull. 2013;39(4):776–86.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bushnell MC, Ceko M, Low LA. Cognitive and emotional control of pain and its disruption in chronic pain . Nat Rev Neurosci. 2013;14(7):502–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Capuron L, Ravaud A, Dantzer R. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J Clin Oncol. 2000;18(10):2143–51.

    Article  CAS  PubMed  Google Scholar 

  • Celano CM, Huffman JC. Depression and cardiac disease: a review. Cardiol Rev. 2011;19(3):130–42.

    Article  PubMed  Google Scholar 

  • Chappell AS, Bradley LA, Wiltse C, Detke MJ, D’Souza DN, Spaeth M. A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia. Int J Gen Med. 2008;30(1):91–102.

    Article  Google Scholar 

  • Clark AK, Old EA, Malcangio M. Neuropathic pain and cytokines: current perspectives. J Pain Res. 2013;21(6):803–14.

    Google Scholar 

  • Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatr. 2013;58(7):376–85.

    Article  Google Scholar 

  • Delgado PL. Depression: the case for a monoamine deficiency. J Clin Psychiatry. 2000;61(Supp 6):7–11.

    CAS  PubMed  Google Scholar 

  • Dharmshaktu P, Tayal V, Kalra BS. Efficacy of antidepressants as analgesics: a review. J Clin Pharmacol. 2012;52(1):6–17.

    Article  CAS  PubMed  Google Scholar 

  • Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, LanctĂŽt KL. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–57.

    Article  CAS  PubMed  Google Scholar 

  • Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, HaanpÀÀ ML, Kent JL, Krane EJ, Lebel AA, Levy RM, Mackey SC, Mayer J, Miaskowski C, Raja SN, Rice AS, Schmader KE, Stacey B, Stanos S, Treede RD, Turk DC, Walco GA, Wells CD. Recommendations for the pharmacological management of neuropathic pain : an overview and literature update. Mayo Clin Proc. 2010;85(Suppl 3):S3–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ellis A, Bennett DL. Neuroinflammation and the generation of neuropathic pain . Br J Anaesth. 2013;111(1):26–3766.

    Article  CAS  PubMed  Google Scholar 

  • Euteneuer F, Schwarz MJ, Hennings A, Riemer S, Stapf T, Selberdinger V, Rief W. Depression, cytokines and experimental pain : evidence for sex-related association patterns. J Affect Disord. 2011;131(1–3):143–9.

    Google Scholar 

  • Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? J Clin Psychiatry. 2004;65(4):521–30102.

    Article  CAS  PubMed  Google Scholar 

  • Felger JC. The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications. Curr Top Behav Neurosci. 2017;31:199–219.

    Article  PubMed  CAS  Google Scholar 

  • Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, HaanpÀÀ M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–73.

    Google Scholar 

  • Fitzgerald PB, Laird AR, Maller J, Daskalakis ZJ. A meta-analytic study of changes in brain activation in depression. Hum Brain Mapp. 2008;29(6):683–95.

    Article  PubMed  Google Scholar 

  • Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut. 2009;58(3):367–78.

    Article  CAS  PubMed  Google Scholar 

  • Fuxe K, Borroto-Escuela DO. Basimglurant for treatment of major depressive disorder: a novel negative allosteric modulator of metabotropic glutamate receptor 5. Expert Opin Investig Drugs. 2015;24(9):1247–60.

    Article  CAS  PubMed  Google Scholar 

  • Gebhardt S, Heinzel-Gutenbrunner M, König U. Pain relief in depressive disorders: a meta-analysis of the effects of antidepressants. J Clin Psychopharmacol. 2016;36(6):658–68.

    Article  CAS  PubMed  Google Scholar 

  • Generaal E, Milaneschi Y, Jansen R, Elzinga BM, Dekker J, Penninx BW. The brain-derived neurotrophic factor pathway, life stress, and chronic multi-site musculoskeletal pain . Mol Pain. 2016;12:1–9.

    Article  CAS  Google Scholar 

  • Geracioti TD Jr, Carpenter L, Owens MJ, Baker DG, Ekhator NN, Horn PS, Strawn JR, Sanacora G, Kinkead B, Price LH, Nemeroff CB. Elevated cerebrospinal fluid substance p concentrations in post-traumatic stress disorder and major depression. Am J Psychiatry. 2006;163(4):637–43.

    Article  PubMed  Google Scholar 

  • Golubeva AV, Moloney RD, O'Connor RM, Dinan TG, Cryan JF. Metabotropic glutamate receptors in central nervous system diseases. Curr Drug Targets. 2016;17(5):538–616.

    Article  CAS  PubMed  Google Scholar 

  • Goodwin RD, Fergusson DM, Horwood LJ. Asthma and depressive and anxiety disorders among young persons in the community. Psychol Med. 2004;34(8):1465–74.

    Article  PubMed  Google Scholar 

  • Graff-Guerrero A, Pellicer F, Mendoza-Espinosa Y, MartĂ­nez-Medina P, Romero-Romo J, de la Fuente-Sandoval C. Cerebral blood flow changes associated with experimental pain stimulation in patients with major depression. J Affect Disord. 2008;107(1–3):161–8.

    Article  PubMed  Google Scholar 

  • Griebeler ML, Morey-Vargas OL, Brito JP, Tsapas A, Wang Z, Carranza Leon BG, Phung OJ, Montori VM, Murad MH. Pharmacologic interventions for painful diabetic neuropathy: an umbrella systematic review and comparative effectiveness network meta-analysis. Ann Intern Med. 2014;161(9):639–49.

    Article  PubMed  Google Scholar 

  • Haas L, Portela LV, Böhmer AE, Oses JP, Lara DR. Increased plasma levels of brain derived neurotrophic factor (BDNF) in patients with fibromyalgia. Neurochem Res. 2010;35(5):830–4.

    Article  CAS  PubMed  Google Scholar 

  • Hagelberg N, Forssell H, Aalto S, Rinne JO, Scheinin H, Taiminen T, NĂ„gren K, Eskola O, JÀÀskelĂ€inen SK. Altered dopamine D2 receptor binding in atypical facial pain . Pain. 2003a;106(1–2):43–8.

    Article  CAS  PubMed  Google Scholar 

  • Hagelberg N, Forssell H, Rinne JO, Scheinin H, Taiminen T, Aalto S, Luutonen S, NĂ„gren K, JÀÀskelĂ€inen S. Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain. 2003b;101(1–2):149–54.

    Article  CAS  PubMed  Google Scholar 

  • Hashimoto K. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev. 2009;61(2):105–23.

    Article  CAS  PubMed  Google Scholar 

  • HĂ€user W, Wolfe F, Tölle T, Uçeyler N, Sommer C. The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs. 2012;26(4):297–307.

    Article  PubMed  Google Scholar 

  • Hayley S, Poulter MO, Merali Z, Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience. 2005;135(3):659–78.

    Article  CAS  PubMed  Google Scholar 

  • Hoffman BM, Papas RK, Chatkoff DK, Kerns RD. Meta-analysis of psychological interventions for chronic low back pain . Health Psychol. 2007;26(1):1–9.

    Article  PubMed  Google Scholar 

  • Huang X, Li C, Luo YL, Wang B, Ji JL. Efficacy of venlafaxine extended-release monotherapy for first-episode depression with painful physical symptoms. Neuroreport. 2013;24(7):364–9.

    Article  CAS  PubMed  Google Scholar 

  • Ivo R, Nicklas A, Dargel J, Sobottke R, Delank KS, Eysel P, Weber B. Brain structural and psychometric alterations in chronic low back pain . Eur Spine J. 2013;22(9):1958–64.

    Article  PubMed  PubMed Central  Google Scholar 

  • Jaracz J, Gattner K, Moczko J, Hauser J. Comparison of the effects of escitalopram and nortriptyline on painful symptoms in patients with major depression. Gen Hosp Psychiatry. 2015;37(1):36–9.

    Article  PubMed  Google Scholar 

  • Jarcho JM, Mayer EA, Jiang ZK, Feier NA, London ED. Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain. 2012;153(4):744–54.

    Article  CAS  PubMed  Google Scholar 

  • Jeon SW, Kim YK. Neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness? World J Psychiatry. 2016;6(3):283–93.

    Article  PubMed  PubMed Central  Google Scholar 

  • Jones AK, Derbyshire SW. Reduced cortical responses to noxious heat in patients with rheumatoid arthritis. Ann Rheum Dis. 1997;56(10):601–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kapur BM, Lala PK, Shaw JL. Pharmacogenetics of chronic pain management. Clin Biochem. 2014;47(13–14):1169–87.

    Google Scholar 

  • Keller M, Montgomery S, Ball W, Morrison M, Snavely D, Liu G, Hargreaves R, Hietala J, Lines C, Beebe K, Reines S. Lack of efficacy of the substance P (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol Psychiatry. 2006;59(3):216–23.

    Article  CAS  PubMed  Google Scholar 

  • Kimbrell TA, Ketter TA, George MS, Little JT, Benson BE, Willis MW, Herscovitch P, Post RM. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry. 2002;51(3):237–52.

    Article  CAS  PubMed  Google Scholar 

  • Kishimoto T, Chawla JM, Hagi K, Zarate CA, Kane JM, Bauer M, Correll CU. Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories. Psychol Med. 2016;46(7):1459–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams AR, Hewson L, Smith D, Carlson EJ, Hargreaves RJ, Rupniak NM. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science. 1998;281(5383):1640–5.

    Article  CAS  PubMed  Google Scholar 

  • Krebs EE, Gaynes BN, Gartlehner G, Hansen RA, Thieda P, Morgan LC, DeVeaugh-Geiss A, Lohr KN. Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and metaanalysis. Psychosomatics. 2008;49(3):191–8.

    Article  PubMed  Google Scholar 

  • Kroenke K, Bair MJ, Damush TM, Wu J, Hoke S, Sutherland J, Tu W. Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain : a randomized controlled trial. JAMA. 2009;301(20):2099–110.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kroenke K, Wu J, Bair MJ, Krebs EE, Damush TM, Tu W. Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain. 2011;12(9):964–73.

    Google Scholar 

  • Kuchinad A, Schweinhardt P, Seminowicz DA, Wood PB, Chizh BA, Bushnell MC. Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain? J Neurosci. 2007;27(15):4004–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet. 2012;379(9820):1045–55.

    Article  PubMed  Google Scholar 

  • Lee MC, Tracey I. Unravelling the mystery of pain , suffering, and relief with brain imaging. Curr Pain Headache Rep. 2010;14(2):124–31.

    Article  PubMed  Google Scholar 

  • Li CT, Su TP, Wang SJ, Tu PC, Hsieh JC. Prefrontal glucose metabolism in medication-resistant major depression. Br J Psychiatry. 2015;206(40):316–23.

    Article  PubMed  Google Scholar 

  • Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-αa) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord. 2012;139(3):230–9.

    Article  CAS  PubMed  Google Scholar 

  • Loggia ML, Berna C, Kim J, Cahalan CM, Martel MO, Gollub RL, Wasan AD, Napadow V, Edwards RR. The lateral prefrontal cortex mediates the hyperalgesic effects of negative cognitions in chronic pain patients. J Pain. 2015;16(8):692–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • LĂłpez-SolĂ  M, Pujol J, HernĂĄndez-Ribas R, Harrison BJ, Contreras-RodrĂ­guez O, Soriano-Mas C, Deus J, Ortiz H, MenchĂłn JM, Vallejo J, Cardoner N. Effects of duloxetine treatment on brain response to painful stimulation in major depressive disorder. Neuropsychopharmacology. 2010;35(11):2305–17.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lorenz J, Minoshima S, Casey KL. Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. Brain. 2003;126(Pt 5):1079–91.

    Article  CAS  PubMed  Google Scholar 

  • Luo YL, Zhang MY, Wu WY, Li CB, Lu Z, Li QW. A randomized double-blind clinical trial on analgesic efficacy of fluoxetine for persistent somatoform pain disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009;33(8):1522–96.

    Article  CAS  PubMed  Google Scholar 

  • Maes M, Mihaylova I, Kubera M, Ringel K. Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2012;36(1):169–75.

    Article  Google Scholar 

  • Mallinckrodt CH, Goldstein DJ, Detke MJ, Lu Y, Watkin JG, Tran PV. Duloxetine: a new treatment for the emotional and physical symptoms of depression. Prim Care Companion J Clin Psychiatry. 2003;5(1):19–28.

    Article  Google Scholar 

  • Martinez JM, Katon W, Greist JH, Kroenke K, Thase ME, Meyers AL, Edwards SE, Marangell LB, Shoemaker S, Swindle R. A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode. Int Clin Psychopharmacol. 2012;27(1):17–26.

    Article  PubMed  Google Scholar 

  • Masand PS, Pae C-U, Krulewicz S, Peindl K, Mannelli P, Varia IM, Patkar AA. A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome. Psychosomatics. 2009;50(1):78–86.

    Article  CAS  PubMed  Google Scholar 

  • Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, Silva JA, Tekell JL, Martin CC, Lancaster JL, Fox PT. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry. 1999;156(5):675–82.

    CAS  PubMed  Google Scholar 

  • McCrae CS, O'Shea AM, Boissoneault J, Vatthauer KE, Robinson ME, Staud R, Perlstein WM, Craggs JG. Fibromyalgia patients have reduced hippocampal volume compared with healthy controls. J Pain Res. 2015;8:47–52.

    Article  PubMed  PubMed Central  Google Scholar 

  • Miller AH, Maletic V, Raison CL. The role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mitsi V, Zachariou V. Modulation of pain , nociception, and analgesia by the brain reward center. Neuroscience. 2016;338:81–92.

    Article  CAS  PubMed  Google Scholar 

  • Molendijk ML, Spinhoven P, Polak M, Bus BA, Penninx BW, Elzinga BM. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484). Mol Psychiatry. 2014;19(7):791–800.

    Article  CAS  PubMed  Google Scholar 

  • Monticone M, Cedraschi C, Ambrosini E, Rocca B, Fiorentini R, Restelli M, Gianola S, Ferrante S, Zanoli G, Moja L. Cognitive-behavioural treatment for subacute and chronic neck pain L. Cochrane Database Syst Rev. 2015;5:CD010664.

    Google Scholar 

  • MĂŒller N. Immunology of major depression. Neuroimmunomodulation. 2014;21(2–3):123–30.

    Article  PubMed  CAS  Google Scholar 

  • Murphy LB, Sacks JJ, Brady TJ, Hootman JM, Chapman DP. Anxiety and depression among US adults with arthritis: prevalence and correlates. Arthritis Care Res. 2012;64(7):968–76.

    Google Scholar 

  • Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med. 2001;344(13):961–6.

    Article  CAS  PubMed  Google Scholar 

  • Mutschler I, Ball T, Wankerl J, Strigo IA. Pain and emotion in the insular cortex: evidence for functional reorganization in major depression. Neurosci Lett. 2012;520(2):204–957.

    Article  CAS  PubMed  Google Scholar 

  • Nestler EJ, Carlezon WA Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry. 2006;59(12):1151–9.

    Article  CAS  PubMed  Google Scholar 

  • Nijs J, Meeus M, Versijpt J, Moens M, Bos I, Knaepen K, Meeusen R. Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain : a new therapeutic target? Expert Opin Ther Targets. 2015;19(4):565–76.

    Article  PubMed  CAS  Google Scholar 

  • Nugraha B, Korallus C, Gutenbrunner C. Serum level of brain-derived neurotrophic factor in fibromyalgia syndrome correlates with depression but not anxiety. Neurochem Int. 2013;62(3):281–6.

    Article  CAS  PubMed  Google Scholar 

  • Ossipov MH, Morimura K, Porreca F. Descending pain modulation and chronification of pain . Curr Opin Support Palliat Care. 2014;8(2):143–51.78.

    Google Scholar 

  • Perahia DG, Quail D, Desaiah D, Montejo AL, Schatzberg AF. Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: effects on painful physical symptoms of depression. J Psychiatr Res. 2009;43(5):512–8.

    Article  PubMed  Google Scholar 

  • Pickering M, O’Connor JJ. Pro-inflammatory cytokines and their effects in the dentate gyrus. Prog Brain Res. 2007;163:339–54.

    Article  CAS  PubMed  Google Scholar 

  • Raskin J, Wiltse CG, Siegal A, Sheikh J, Xu J, Dinkel JJ, Rotz BT, Mohs RC. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am J Psychiatry. 2007;164(6):900–9.

    Article  PubMed  Google Scholar 

  • Ratti E, Bettica P, Alexander R, Archer G, Carpenter D, Evoniuk G, Gomeni R, Lawson E, Lopez M, Millns H, Rabiner EA, Trist D, Trower M, Zamuner S, Krishnan R, Fava M. Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies. J Psychopharmacol. 2013;27(5):424–34.

    Article  CAS  PubMed  Google Scholar 

  • Reese C, Mittag O. Psychological interventions in the rehabilitation of patients with chronic low back pain : evidence and recommendations from systematic reviews and guidelines. Int J Rehabil Res. 2013;36(1):6–12.

    Article  PubMed  Google Scholar 

  • Rej S, Dew MA, Karp JF. Treating concurrent chronic low back pain and depression with low-dose venlafaxine: an initial identification of “easy-to-use” clinical predictors of early response. Pain Med. 2014;15(7):1154–62.

    Article  PubMed  Google Scholar 

  • Robinson ME, Craggs JG, Price DD, Perlstein WM, Staud R. Gray matter volumes of pain -related brain areas are decreased in fibromyalgia syndrome. J Pain. 2011;12(4):436–43.

    Google Scholar 

  • Robinson MJ, Sheehan D, Gaynor PJ, Marangell LB, Tanaka Y, Lipsius S, Ohara F, Namiki C. Relationship between major depressive disorder and associated painful physical symptoms: analysis of data from two pooled placebo-controlled, randomized studies of duloxetine. Int Clin Psychopharmacol. 2013;28(6):330–8.

    Article  PubMed  Google Scholar 

  • Romera I, Perez V, Manuel Menchon J, Schacht A, Papen R, Neuhauser D, Abbar M, Picard H, Gilaberte I. Early vs. conventional switching of antidepressants in patients with MDD and moderate to severe pain : a double-blind randomized study. J Affect Disord. 2012;143(1–3):47–55.

    Article  CAS  PubMed  Google Scholar 

  • SaadĂ© NE, Atweh SF, Bahuth NB, Jabbur SJ. Augmentation of nociceptive reflexes and chronic deafferentation pain by chemical lesions of either dopaminergic terminals or midbrain dopaminergic neurons. Brain Res. 1997;751(1):1–12.

    Article  PubMed  Google Scholar 

  • Schaible HG. Nociceptive neurons detect cytokines in arthritis. Arthritis Res Ther. 2014;16(5):470.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Schneider E, Linden M, Weigmann H, Wagner T, Quail D, Hundemer HP, Hegerl U. Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine. BMC Psychiatry. 2011;11:150.

    Article  PubMed  PubMed Central  Google Scholar 

  • Shubayev VI, Kato K, Myers RR. Cytokines in pain . In: Kruger L, Light AR, editors. Source translational pain research: from mouse to man. Boca Raton: CRC Press/Taylor & Francis; 2010.

    Google Scholar 

  • Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014;140(3):774–815.

    Article  PubMed  PubMed Central  Google Scholar 

  • Stahl S. The psychopharmacology of painful symptoms in depression. J Clin Psychiatry. 2002;63(5):382–3.

    Article  PubMed  Google Scholar 

  • Strigo I, Simmons A, Matthews S, Craig A, Paulus M. Association of major depressive disorder with altered functional brain response during anticipation and processing of heat pain . Arch Gen Psychiatry. 2008;65(11):1275–84.

    Article  PubMed  PubMed Central  Google Scholar 

  • Strigo IA, Matthews SC, Simmons AN. Right anterior insula hypoactivity during anticipation of homeostatic shifts in major depressive disorder. Psychosom Med. 2010;72(3):316–23.

    Article  PubMed  PubMed Central  Google Scholar 

  • Tack J, Broekaert D, Fischler B, Van Oudenhove L, Gevers AM, Janssens J. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut. 2006;55(8):1095–103.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Thielke S, Corson K, Dobscha SK. Collaborative care for pain results in both symptom improvement and sustained reduction of pain and depression. Gen Hosp Psychiatry. 2015;37(2):139–43.

    Google Scholar 

  • Vahedi H, Merat S, Rashidioon A, Ghoddoosi A, Malekzadeh R. The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study. Aliment Pharmacol Ther. 2005;22(5):381–5.

    Article  CAS  PubMed  Google Scholar 

  • VanderWeide LA, Smith SM, Trinkley KE. A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia. J Clin Pharm Ther. 2015;40(1):1–6.

    Article  CAS  PubMed  Google Scholar 

  • Veehof MM, Oskam MJ, Schreurs KM, Bohlmeijer ET. Acceptance-based interventions for the treatment of chronic pain : a systematic review and meta-analysis. Pain. 2011;152(3):533–542.

    Article  PubMed  Google Scholar 

  • Walitt B, UrrĂștia G, Nishishinya MB, Cantrell SE, HĂ€user W. Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Cochrane Database Syst Rev. 2015;6:CD011735.

    Google Scholar 

  • Walker JR, Ediger JP, Graff LA, Greenfeld JM, Clara I, Lix L, Rawsthorne P, Miller N, Rogala L, McPhail CM, Bernstein CN. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008;103(8):1989–97.

    Article  PubMed  Google Scholar 

  • Wiech K, Ploner M, Tracey I. Neurocognitive aspects of pain perception. Trends Cogn Sci. 2008;12(8):306–13.

    Google Scholar 

  • Xie C, Tang Y, Wang Y, Yu T, Wang Y, Jiang L, Lin L. Efficacy and safety of antidepressants for the treatment of irritable bowel syndrome: a meta-analysis. PLoS One. 2015;10(8):e0127815.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Young JJ, Bruno D, Pomara N. A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord. 2014;169:15–20.

    Article  CAS  PubMed  Google Scholar 

  • Yu YB, Zuo XL, Zhao QJ, Chen FX, Yang J, Dong YY, Wang P, Li YQ. Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome. Gut. 2012;61(5):685–94.

    Google Scholar 

  • Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM. Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2011;35(3):722–9.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Adult Psychiatry, Poznan University of Medical Sciences, PoznaƄ, Poland

    Jan Jaracz

Authors
  1. Jan Jaracz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan Jaracz .

Editor information

Editors and Affiliations

  1. College of Medicine, Korea University, Kyonggi-do, Korea (Republic of)

    Yong-Ku Kim

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Jaracz, J. (2018). Overlapping Chronic Pain and Depression: Pathophysiology and Management. In: Kim, YK. (eds) Understanding Depression. Springer, Singapore. https://doi.org/10.1007/978-981-10-6577-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-6577-4_12

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-6576-7

  • Online ISBN: 978-981-10-6577-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation